# Trade Mark Journal No.2026/005 30 January 2026

## WO0000001896655 (5,42)

Office of origin: United States of America

Date of International Registration:12 November 2025
Date of designation in the UK: 12 November 2025

The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.

International priority date claimed: 8 August 2025 (United States of America) (99328453)

Class 5
  Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders.
Class 42
  Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; research and development services in the field of pharmaceutical and biologic preparations; research and development services in the field of oncology-related diseases and disorders; research and development services in the field of metabolic-related diseases and disorders; research and development services in the field of endocrine-related diseases and disorders; research and development services in the fields of diabetes and obesity-related diseases and disorders; research and development services in the field of peptide pharmaceutical preparations; providing medical and scientific research information in the field of small-molecule drugs; providing medical and scientific research information in the field of clinical trials and post-market trials; providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders.

Terns Pharmaceuticals, Inc.

Representative: Tiffany D. Gehrke Marshall, Gerstein & Borun LLP, 233 South Wacker Drive,, Suite 6300, Chicago IL 60606, UNITED STATES OF AMERICA